Analyst Ratings for MetLife (MET)
MET Rating Summary
MET Price Target Summary
- Highest: $111.00 (Morgan Stanley)
- Lowest: $80.00 (BMO Capital)
- Average: $105.92
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$105.92 (+5.1%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 74%
Avg. $ Target:
$105.92 (+5.1%)
* Over Last 12-Mos
Rating Score: 7 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/22/2026 | Piper Sandler | Paul Newsome | Upgrade | Overweight (Neutral) |
110.00 (99.00) |
97.04 (100.76) |
3.83% | Details |
| 1/6/2026 | Evercore ISI » Updated 8/24/2026 |
Thomas Gallagher | Downgrade | In Line (Outperform) |
106.00 (103.00) |
80.32 (100.76) |
25.45% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||



